PTK2 and breast carcinoma: Only recently was NC found to inhibit the phosphorylation of c-Src, FAK, MAPKs, and inhibit the activation of RhoA, Rac1, and AP-1 transcriptional activity induced by PDGF in breast cancer cells7.